AstraZeneca is not out of the woods yet. Still, the multinational pharmaceutical company now has at least one foot in the proverbial clearing, following the formal termination of protracted litigation it was engaged in with the State of Texas….

Federal authorities reportedly ratcheted up their focus on the Dallas area as a hotbed of health care fraud activity some time ago. The heightened scrutiny commenced as an offshoot of federal investigatory efforts that The Dallas Morning News states…

Recently incoming Federal Housing Administration Commissioner Brian Montgomery refers to a “bright line” when discussing FHA lending programs to the country’s consumers. Bottom line: He laments that it is, well, not bright. In fact, he stresses that transparency and…